Skip to content

Exagen Inc. XGN Enterprise value

Enterprise value at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$28.24B+10.2%
Quest Diagnostics logo
Quest DiagnosticsDGX
$27.54B+9.5%
Vor Biopharma logo
Vor BiopharmaVOR
$704.51M+902%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$315.24M+909%
CareDx logo
CareDxCDNA
$835.14M-9.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$8B+4.2%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Calculated from Exagen Inc.’s reported figures.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s enterprise value?
Exagen Inc. (XGN) reported enterprise value of $77.59M in Q1 2026.
How has Exagen Inc.'s enterprise value changed year-over-year?
Exagen Inc.'s enterprise value increased by 1.7% year-over-year, from $76.3M to $77.59M.
What is the long-term trend for Exagen Inc.'s enterprise value?
Over 5 years (2020 to 2025), Exagen Inc.'s enterprise value has grown at a -6.4% compound annual growth rate (CAGR), from $184.94M to $133.04M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.